BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 25188740)

  • 1. Transcription-mediated chimeric RNAs in prostate cancer: time to revisit old hypothesis?
    Ren G; Zhang Y; Mao X; Liu X; Mercer E; Marzec J; Ding D; Jiao Y; Qiu Q; Sun Y; Zhang B; Yeste-Velasco M; Chelala C; Berney D; Lu YJ
    OMICS; 2014 Oct; 18(10):615-24. PubMed ID: 25188740
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical utility of a novel urine-based gene fusion TTTY15-USP9Y in predicting prostate biopsy outcome.
    Zhu Y; Ren S; Jing T; Cai X; Liu Y; Wang F; Zhang W; Shi X; Chen R; Shen J; Lu J; Xu C; Wang H; Wang H; Wang Y; Liu B; Li Y; Fang Z; Guo F; Qiao M; Shen D; Lu X; Gao X; Hou J; Sun Y
    Urol Oncol; 2015 Sep; 33(9):384.e9-20. PubMed ID: 26008593
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chimeric transcript generated by cis-splicing of adjacent genes regulates prostate cancer cell proliferation.
    Zhang Y; Gong M; Yuan H; Park HG; Frierson HF; Li H
    Cancer Discov; 2012 Jul; 2(7):598-607. PubMed ID: 22719019
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SLC45A3-ELK4 functions as a long non-coding chimeric RNA.
    Qin F; Zhang Y; Liu J; Li H
    Cancer Lett; 2017 Sep; 404():53-61. PubMed ID: 28716526
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SLC45A3-ELK4 is a novel and frequent erythroblast transformation-specific fusion transcript in prostate cancer.
    Rickman DS; Pflueger D; Moss B; VanDoren VE; Chen CX; de la Taille A; Kuefer R; Tewari AK; Setlur SR; Demichelis F; Rubin MA
    Cancer Res; 2009 Apr; 69(7):2734-8. PubMed ID: 19293179
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SLC45A3-ELK4 chimera in prostate cancer: spotlight on cis-splicing.
    Kumar-Sinha C; Kalyana-Sundaram S; Chinnaiyan AM
    Cancer Discov; 2012 Jul; 2(7):582-5. PubMed ID: 22787087
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of CTCF in Regulating SLC45A3-ELK4 Chimeric RNA.
    Qin F; Song Y; Zhang Y; Facemire L; Frierson H; Li H
    PLoS One; 2016; 11(3):e0150382. PubMed ID: 26938874
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RNA-seq analysis of prostate cancer in the Chinese population identifies recurrent gene fusions, cancer-associated long noncoding RNAs and aberrant alternative splicings.
    Ren S; Peng Z; Mao JH; Yu Y; Yin C; Gao X; Cui Z; Zhang J; Yi K; Xu W; Chen C; Wang F; Guo X; Lu J; Yang J; Wei M; Tian Z; Guan Y; Tang L; Xu C; Wang L; Gao X; Tian W; Wang J; Yang H; Wang J; Sun Y
    Cell Res; 2012 May; 22(5):806-21. PubMed ID: 22349460
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High frequency of the SDK1:AMACR fusion transcript in Chinese prostate cancer.
    Zhang Y; Mao XY; Liu X; Song RR; Berney D; Lu YJ; Ren G
    Int J Clin Exp Med; 2015; 8(9):15127-36. PubMed ID: 26628996
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential expression of ETS family members in prostate cancer tissues and androgen-sensitive and insensitive prostate cancer cell lines.
    Adler D; Lindstrot A; Langer B; Buettner R; Wernert N
    Int J Mol Med; 2011 Jul; 28(1):89-93. PubMed ID: 21491078
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A variant of the KLK4 gene is expressed as a cis sense-antisense chimeric transcript in prostate cancer cells.
    Lai J; Lehman ML; Dinger ME; Hendy SC; Mercer TR; Seim I; Lawrence MG; Mattick JS; Clements JA; Nelson CC
    RNA; 2010 Jun; 16(6):1156-66. PubMed ID: 20406994
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel transcription-induced fusion RNAs in prostate cancer.
    Zhao S; Løvf M; Carm KT; Bakken AC; Hoff AM; Skotheim RI
    Oncotarget; 2017 Jul; 8(30):49133-49143. PubMed ID: 28467780
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Concurrent TMPRSS2-ERG and SLC45A3-ERG rearrangements plus PTEN loss are not found in low grade prostate cancer and define an aggressive tumor subset.
    Hernández S; Font-Tello A; Juanpere N; de Muga S; Lorenzo M; Salido M; Fumadó L; Serrano L; Cecchini L; Serrano S; Lloreta J
    Prostate; 2016 Jun; 76(9):854-65. PubMed ID: 26959281
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FLI1 is a novel ETS transcription factor involved in gene fusions in prostate cancer.
    Paulo P; Barros-Silva JD; Ribeiro FR; Ramalho-Carvalho J; Jerónimo C; Henrique R; Lind GE; Skotheim RI; Lothe RA; Teixeira MR
    Genes Chromosomes Cancer; 2012 Mar; 51(3):240-9. PubMed ID: 22081504
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of ETS-like transcription factor 4 as a novel androgen receptor target in prostate cancer cells.
    Makkonen H; Jääskeläinen T; Pitkänen-Arsiola T; Rytinki M; Waltering KK; Mättö M; Visakorpi T; Palvimo JJ
    Oncogene; 2008 Aug; 27(36):4865-76. PubMed ID: 18469865
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loss of SLC45A3 protein (prostein) expression in prostate cancer is associated with SLC45A3-ERG gene rearrangement and an unfavorable clinical course.
    Perner S; Rupp NJ; Braun M; Rubin MA; Moch H; Dietel M; Wernert N; Jung K; Stephan C; Kristiansen G
    Int J Cancer; 2013 Feb; 132(4):807-12. PubMed ID: 22821757
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rearrangements of the RAF kinase pathway in prostate cancer, gastric cancer and melanoma.
    Palanisamy N; Ateeq B; Kalyana-Sundaram S; Pflueger D; Ramnarayanan K; Shankar S; Han B; Cao Q; Cao X; Suleman K; Kumar-Sinha C; Dhanasekaran SM; Chen YB; Esgueva R; Banerjee S; LaFargue CJ; Siddiqui J; Demichelis F; Moeller P; Bismar TA; Kuefer R; Fullen DR; Johnson TM; Greenson JK; Giordano TJ; Tan P; Tomlins SA; Varambally S; Rubin MA; Maher CA; Chinnaiyan AM
    Nat Med; 2010 Jul; 16(7):793-8. PubMed ID: 20526349
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Whole-transcriptome analysis reveals established and novel associations with TMPRSS2:ERG fusion in prostate cancer.
    Chow A; Amemiya Y; Sugar L; Nam R; Seth A
    Anticancer Res; 2012 Sep; 32(9):3629-41. PubMed ID: 22993300
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Long Noncoding RNA TTTY15, Which Is Located on the Y Chromosome, Promotes Prostate Cancer Progression by Sponging let-7.
    Xiao G; Yao J; Kong D; Ye C; Chen R; Li L; Zeng T; Wang L; Zhang W; Shi X; Zhou T; Li J; Wang Y; Xu CL; Jiang J; Sun Y
    Eur Urol; 2019 Sep; 76(3):315-326. PubMed ID: 30527798
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distinct classes of chromosomal rearrangements create oncogenic ETS gene fusions in prostate cancer.
    Tomlins SA; Laxman B; Dhanasekaran SM; Helgeson BE; Cao X; Morris DS; Menon A; Jing X; Cao Q; Han B; Yu J; Wang L; Montie JE; Rubin MA; Pienta KJ; Roulston D; Shah RB; Varambally S; Mehra R; Chinnaiyan AM
    Nature; 2007 Aug; 448(7153):595-9. PubMed ID: 17671502
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.